Alcon Inc. (ALC)

Market Cap	38.48B
Revenue (ttm)	9.09B
Net Income (ttm)	362.00M
Shares Out	491.80M
EPS (ttm)	0.72
PE Ratio	108.68
Forward PE	26.44
Dividend	$0.24 (0.30%)
Ex-Dividend Date	May 10, 2023

Volume	700,802
Open	78.37
Previous Close	78.37
Day's Range	78.17 - 78.79
52-Week Range	55.21 - 86.20
Beta	0.69
Analysts	Buy
Price Target	88.53 (+13.14%)
Earnings Date	Nov 14, 2023

About ALC

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx laser system, LuxOR surgical ophthalmic microscope,...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1945
• Employees: 25,178
• Stock Exchange: NYSE
• Ticker Symbol: ALC

Financial Performance

In 2022, Alcon's revenue was $8.72 billion, an increase of 5.14% compared to the previous year's $8.29 billion. Earnings were $335.00 million, a decrease of -10.90%.

Analyst Forecast

According to 11 analysts, the average rating for ALC stock is "Buy." The 12-month stock price forecast is $88.53, which is an increase of 13.14% from the latest price.

Price Target

$88.53

(13.14% upside)

Analyst Consensus: Buy